Non-invasive Ventilation: A Gimmick or Does it Really Affect Outcomes?
Non-invasive Ventilation: A Gimmick or Does it Really Affect Outcomes?
复制标题
无创通气：一个噱头还是真的会影响结果？
DOI：
10.1007/s40138-015-0071-0
复制
发表时间：
2015
影响因子：
0.7
通讯作者：
Collins,Sean
中科院分区：
文献类型：
--
作者：
Behringer,TiffanyS;Collins,Sean
心力衰竭每年影响510万美国人，每年导致超过90万的急诊就诊。在这些患者中，超过80%的人将住院。在ED中，治疗的重点是通过使用利尿剂和血管扩张剂减少前负荷和后负荷。对于需要吸氧的患者，特别是呼吸窘迫患者，无创通气可通过增加通气、减少前负荷和后负荷、减少呼吸功和增加气体交换来改善症状。无创通气是一种有效的干预措施，被认为是ED合并急性心力衰竭患者治疗的重要组成部分。
Heart failure affects 5.1 million Americans every year and leads to over 900,000 annual emergency department (ED) visits. Of those patients, over 80 % will be admitted to the hospital. In the ED, treatment focuses on preload and afterload reduction through the use of diuretics and vasodilators. For those patients requiring oxygen, particularly those in respiratory distress, non-invasive ventilation improves symptoms by increasing ventilation, decreasing preload and afterload, decreasing work of breathing, and increasing gas exchange. Non-invasive ventilation is an effective intervention and is considered an important component of therapy in ED patients with acute heart failure.